Comparison of airway immunopathology of eosinophilic bronchitis and asthma.

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.

BACKGROUND: Eosinophilic bronchitis is a condition characterised by a corticosteroid responsive cough, sputum eosinophilia, and normal tests of variable airflow obstruction and airway responsiveness. We performed a detailed comparative immunopathological study to test the hypothesis that the differe...

Detaylı Bibliyografya
Asıl Yazarlar:	Brightling, C, Symon, F, Birring, S, Bradding, P, Wardlaw, A, Pavord, I
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2003

Benzer Materyaller

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
Yazar:: Siddiqui, S, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Mast-cell infiltration of airway smooth muscle in asthma.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
Yazar:: Berry, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Eosinophilic bronchitis: clinical features, management and pathogenesis.
Yazar:: Birring, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The significance of eosinophilic airway inflammation in asthma
Yazar:: Pavord, I, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Eosinophils in asthma and airway hyperresponsiveness.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Eosinophilic bronchitis is an important cause of chronic cough.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
Yazar:: Wardlaw, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Mepolizumab in refractory eosinophilic asthma.
Yazar:: Pavord, I, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Eosinophilic bronchitis - what is it and why is it important?
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Chemokine concentrations and mast cell chemotactic activity in BAL fluid in patients with eosinophilic bronchitis and asthma, and in normal control subjects.
Yazar:: Woodman, L, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Eosinophilic bronchitis: an important cause of prolonged cough.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

New insights into the relationship between airway inflammation and asthma.
Yazar:: Wardlaw, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
Yazar:: Berry, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Observational study of the natural history of eosinophilic bronchitis.
Yazar:: Berry, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Non-eosinophilic corticosteroid unresponsive asthma.
Yazar:: Pavord, I, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
Yazar:: Kulkarni, N, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
Yazar:: Haldar, P, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Yazar:: Green, R, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Eosinophils in asthma and other allergic diseases.
Yazar:: Wardlaw, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
Yazar:: Mistry Vijay, ve diğerleri
Baskı/Yayın Bilgisi: (2009-07-01)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
Yazar:: Berry, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

New insights into the role of the mast cell in asthma.
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
Yazar:: Brightling, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
Yazar:: Shrimanker, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
Yazar:: Haldar, P, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
Yazar:: Bilocca, D, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
Yazar:: Shrimanker, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis.
Yazar:: Birring, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Induced sputum inflammatory mediator concentrations in chronic cough.
Yazar:: Birring, S, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Multiple inflammatory hits and the pathogenesis of severe airway disease.
Yazar:: Pavord, I, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
Yazar:: Haldar, P, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
Yazar:: Haldar, P, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

The identification of eosinophilic gastroenteritis in prednisone-dependent eosinophilic bronchitis and asthma
Yazar:: Nair Parameswaran, ve diğerleri
Baskı/Yayın Bilgisi: (2011-03-01)